NORTH AMERICA VETERINARY VACCINES MARKET FORECAST 2020-2028

NORTH AMERICA VETERINARY VACCINES MARKET FORECAST 2020-2028

  • February 2020 •
  • 156 pages •
  • Report ID: 5867235 •
  • Format: PDF
KEY FINDINGS
The market of veterinary vaccines of North America is predicted to register a CAGR of 6.01% during the projected period, 2020-2028. A surge in companion animal ownership and increasing government initiatives are the significant factors boosting the growth of the market in the region.

MARKET INSIGHTS
The North American market of veterinary vaccines is researched further by dividing the region into the US and Canada.In Canada, veterinary vaccines are regulated by the Canadian Food Inspection Agency.

It is mandatory for all vaccines to be sold in Canada to be registered with the Canadian Centre for Veterinary Biologics.In 2005, to protect Atlantic salmon from hematopoietic necrosis, the first DNA vaccines for edible species were registered in Canada.

Since 2008, the Veterinary Medical Association has revised vaccination protocols for cats and dogs.In Canada, most newborn calves are vaccinated with BVD vaccines, along with Clostridial vaccines.

The Alberta Livestock and Meat Agency Ltd. is aiming at two pathogens, Salmonella and Clostridium perfringens, which affect poultry producers. Ceva produces VECTORMUNE, the broadest range of disease protection in a vector vaccine line of poultry vaccines against diseases, such as Marek’s disease, Newcastle Disease, Fowl Pox, Avian influenza, Mycoplasma, and Avian Encephalomyelitis. The International Development Research Centre started a Livestock Vaccines innovation Fund in 2015, in Canada, which tries to improve the health of livestock and livelihood of farmers, by supporting the production, development, and commercialization of innovative vaccines to fight neglected livestock diseases in Sub-Saharan Africa, South, and South-East Asia. These factors, along with innovation in the development of new animal vaccines, are contemplated to contribute to the growth of the Canadian market.

COMPETITIVE INSIGHTS
Virbac SA, Ceva Santé Animale, The Boehringer Ingelheim group, Merck & Co., Inc., Elanco, etc. are some of the prominent companies operating in the market.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ANICON LABOR GMBH
2. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
3. CEVA SANTE ANIMALE
4. ELANCO (ELI LILLY AND COMPANY)
5. HESTER BIOSCIENCES LIMITED
6. HIPRA
7. HYGIEIA BIOLOGICAL LABORATORIES
8. MERCK & CO.
9. PHIBRO ANIMAL HEALTH CORP.
10. ROMVAC COMPANY S.A.
11. VAXXINOVA GMBH-GERMANY
12. VIRBAC SA
13. ZOETIS ANIMAL HEALTHCARE